CGEN
Price
$1.53
Change
-$0.01 (-0.65%)
Updated
Jul 25 closing price
Capitalization
149.59M
11 days until earnings call
XOMAP
Price
$25.55
Change
-$0.20 (-0.78%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

CGEN vs XOMAP

Header iconCGEN vs XOMAP Comparison
Open Charts CGEN vs XOMAPBanner chart's image
Compugen
Price$1.53
Change-$0.01 (-0.65%)
Volume$219.8K
Capitalization149.59M
XOMA
Price$25.55
Change-$0.20 (-0.78%)
VolumeN/A
CapitalizationN/A
CGEN vs XOMAP Comparison Chart in %
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEN vs. XOMAP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and XOMAP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CGEN: $1.53 vs. XOMAP: $25.75)
Brand notoriety: CGEN and XOMAP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 89% vs. XOMAP: 39%
Market capitalization -- CGEN: $149.59M vs. XOMAP: $0
CGEN [@Biotechnology] is valued at $149.59M. XOMAP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileXOMAP’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • XOMAP’s FA Score: 1 green, 4 red.
According to our system of comparison, both CGEN and XOMAP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while XOMAP’s TA Score has 6 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 5 bearish.
  • XOMAP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XOMAP is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а -0.65% price change this week, while XOMAP (@Biotechnology) price change was +0.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CGEN is expected to report earnings on Nov 06, 2025.

XOMAP is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMAP YTD gains are higher at: 5.962 vs. CGEN (0.000). XOMAP has higher annual earnings (EBITDA): 6M vs. CGEN (-14.79M). CGEN has more cash in the bank: 104M vs. XOMAP (93.3M). CGEN has less debt than XOMAP: CGEN (2.77M) vs XOMAP (114M). CGEN has higher revenues than XOMAP: CGEN (27.6M) vs XOMAP (13M).
CGENXOMAPCGEN / XOMAP
Capitalization150MN/A-
EBITDA-14.79M6M-247%
Gain YTD0.0005.962-
P/E Ratio64.00N/A-
Revenue27.6M13M212%
Total Cash104M93.3M111%
Total Debt2.77M114M2%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENXOMAP
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
10%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
20%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
26%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
21%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
26%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 11 days ago
23%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
19%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 2 days ago
4%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXPRF141.8922.84
+19.19%
Nexans Paris ACT
SZLMY52.650.10
+0.19%
Swiss Life Holding
EESE0.05N/A
N/A
Energy & Environmental Services Inc.
DAWIF10.20N/A
N/A
Daiwa Industires Ltd
WSTRF0.67-0.02
-3.35%
Western Uranium & Vanadium Corp.

XOMAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAP has been loosely correlated with AMLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMAP jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAP
1D Price
Change %
XOMAP100%
N/A
AMLX - XOMAP
51%
Loosely correlated
-1.81%
CGEN - XOMAP
31%
Poorly correlated
-0.65%
RNAC - XOMAP
29%
Poorly correlated
-0.97%
XOMAO - XOMAP
27%
Poorly correlated
-0.01%
MGTX - XOMAP
26%
Poorly correlated
+0.72%
More